Fernández-Esgueva, M., López-Calleja, A. I., Mulet, X., Fraile-Ribot, P. A., Cabot, G., Huarte, R., . . . Oliver, A. (2020). Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy. Enfermedades infecciosas y microbiologia clinica (English ed.), 38(10), 474-478. https://doi.org/10.1016/j.eimce.2020.01.015

Fernández-Esgueva, Marta, Ana Isabel López-Calleja, Xavier Mulet, Pablo A. Fraile-Ribot, Gabriel Cabot, Rafael Huarte, Antonio Rezusta, and Antonio Oliver. "Characterization of AmpC β-lactamase Mutations of Extensively Drug-resistant Pseudomonas Aeruginosa Isolates That Develop Resistance to Ceftolozane/tazobactam During Therapy." Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.) 38, no. 10 (2020): 474-478. https://doi.org/10.1016/j.eimce.2020.01.015.

Fernández-Esgueva, Marta, et al. "Characterization of AmpC β-lactamase Mutations of Extensively Drug-resistant Pseudomonas Aeruginosa Isolates That Develop Resistance to Ceftolozane/tazobactam During Therapy." Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.), vol. 38, no. 10, 2020, pp. 474-478, https://doi.org/10.1016/j.eimce.2020.01.015.